Polymerase Chain Reaction to Diagnose Infective Endocarditis
2005; Lippincott Williams & Wilkins; Volume: 111; Issue: 11 Linguagem: Inglês
10.1161/01.cir.0000160383.67586.7b
ISSN1524-4539
AutoresPeter A. Rice, Guillermo Madico,
Tópico(s)Streptococcal Infections and Treatments
ResumoHomeCirculationVol. 111, No. 11Polymerase Chain Reaction to Diagnose Infective Endocarditis Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBPolymerase Chain Reaction to Diagnose Infective EndocarditisWill It Replace Blood Cultures? Peter A. Rice, MD and Guillermo E. Madico, MD, PhD Peter A. RicePeter A. Rice From the Evans Biomedical Research Center, Boston University Medical Center, Boston, Mass. and Guillermo E. MadicoGuillermo E. Madico From the Evans Biomedical Research Center, Boston University Medical Center, Boston, Mass. Originally published22 Mar 2005https://doi.org/10.1161/01.CIR.0000160383.67586.7BCirculation. 2005;111:1352–1354In this issue of Circulation, Breitkopf and colleagues1 report on a series of 52 excised heart valves on which they performed broad-range polymerase chain reaction (PCR) to identify microbes in valve tissues that were defined as having infective endocarditis (IE). Internal sequencing of amplicons, with specific "nested" primers to identify microbial subspecies, was performed after broad-range PCR. The authors report that on the basis of gross features and histopathology, 22 (42.3%) of the 52 valves, which otherwise had evidence of IE, also had microbial subspecies identified. Eight (44%) of 18 IE valves that were preceded by positive blood cultures, where blood culture data were available, were positive by broad-range PCR. von Reyn's,2 Duke,3 and modified Duke4 criteria use blood cultures as a major clinical criterion to predict IE and histopathologic evidence of IE on cardiac valves as "definite" evidence of IE. Arguably, these two criteria together represent the most definite evidence of disease. Therefore, it may seem enigmatic that between and among major criteria used for the diagnosis of IE, >50% of the valves in the Breitkopf et al series1 did not yield a causative microorganism identified by broad-range PCR. At first glance, broad-range PCR may seem to be a highly sensitive method to detect the presence of microbes. Indeed, this method was ≈3-fold more sensitive than the Gram stains and cultures performed on these tissues combined.See p 1415Drawbacks of PCR: Tradeoffs in Sensitivity and SpecificityBroad-range PCR is used to target commonly shared bacterial 16S rRNA genes (via pan-bacterial primers), and subsequently, direct sequencing is used to detect and differentiate bacteria. Broad-range PCR should be an added benefit to blood cultures to screen for bacteria that may cause IE. In the past, contamination of PCR reactions with irrelevant bacteria had been a major drawback, but it may still occur today even in the face of rigorous techniques intended to prevent contamination of the specimen on which the broad-range PCR is to be performed. Specially designed PCR laboratories and carryover prevention techniques, the latter used by Breitkopf et al,1 also have been invoked to prevent contamination. Carryover prevention uses PCR reactions that substitute uracil for thymidine; subsequent reactions are initiated with uracil-N-glycosylase to degrade uracil containing amplified sequences that may have been carried over from previous reactions. The enzyme is then inactivated with heat before the test sample is added for amplification. Despite the use of preventive measures, wild (unamplified) background bacterial DNA that can attach itself to DNA polymerase may still be present in every reagent used in PCR reactions, including "sterile" water, primer preparations, and nucleic acid extraction reagents.5 Unfortunately, broad-range PCR still has the potential to inappropriately amplify and identify background sequences. This may confound results that yield bacterial species that could be contaminants, some of which (eg, Staphylococcus epidermidis and species of Streptococcus viridans) also can cause IE.Reducing the problem of background contamination in broad-range PCR reactions can be approached6 by selecting primers with intrinsically low sensitivity,7 modifying thermal cycling parameters to obtain low amplification,8,9 or selecting for amplified sequences that exhibit a high signal (eg, via a postamplification colorimetric assay).10 Predigestion of the entire mixture of PCR reaction components with selected restriction enzyme(s) can render contaminating DNA unamplifiable by PCR. The enzyme(s) are then inactivated by heat before the addition of sample DNA. Nonetheless, small amounts of background bacterial DNA may remain, usually introduced during the processing of the specimen (eg, by plasticware, grinders), during DNA extraction (reagents and buffers), or bound to the DNA polymerase.5 Eighty-seven percent sensitivity and specificity versus blood culture was reported in one broad-range PCR approach that used decontamination strategies and tested blood (arguably the specimen of choice to diagnose IE) from 51 febrile intravenous drug users. All 8 patients who had definite IE (infected with S aureus, streptococci, or both) in this group also were positive by broad-range PCR.11 Despite the lower sensitivity reported by Breitkopf et al,1 specificity of the PCR as compared with culture and Gram stain was 100% in excised heart valves with IE. This indicates excellent control of contamination, with only 1 of 16 valves without suspected IE showing a possible contaminant with Aspergillus spp by culture but not by PCR that used fungal primers targeting 18S and 28S rDNA.A disadvantage of these approaches is that DNA from the causative agent(s) must be present at a relatively high concentration to be properly detected. The general result has been that sensitivity achieved by broad-range PCR strategies, particularly for the more common pathogenic agents of IE, often is no better than that with blood culture. Blood cultures were positive in 18 (40%) of 42 IE valves (excluding the single-valve specimen infected with Bartonella quintana) in the series reported by Breitkopf et al,1 in which available blood culture data indicated that the bacteria involved could have been readily cultivated.Highlights of PCRThere are 6 conserved areas in 16S rRNA genes of bacteria (≈1600 bp) that are suitable for use as pan-bacterial primer targets. Successful primer selection must enable amplification of unique bacterial sequences to provide useful data to differentiate most or all of the causative agents involved at the DNA level. Long amplicons provide more information, but they are more difficult to generate, which results in loss of sensitivity. Nested primers that span unique sequences in the 16S rRNA gene in staphylococci and streptococci at the species level (species-specific PCR) also were used in the Breitkopf et al series1; these primers were used in >75% of the PCR assays performed, and the authors believed their use was justified to identify the most commonly anticipated species. There is great advantage in being able to detect bacteria that are difficult to culture (or are uncultivable) by using PCR reactions that target not only 16S rRNA (broad-range PCR) but also other gene sequences that are uniquely species-specific (present in and out of 16S rRNA genes). One fastidious organism, B quintana, was encountered in the Breitkopf et al series, indicating that PCR can be an important adjunct to blood cultures in IE caused by organisms that may not be isolated by standard blood culture systems that do not typically use cell culture (eg, Coxiella burnetii [the agent of Q fever, diagnosed in 5% of cases of endocarditis in France],12Bartonella spp, Chlamydia spp, Tropheryma whippelii [the Whipple's disease bacterium], and other organisms such as the HACEK [Haemophilus aphrophilus, H paraphrophilus, H parainfluenzae, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella spp] group, Legionella spp, and Mycobacterium spp that are simply hard to grow or take a long time to grow in commonly used blood culture systems).Judicious Use of Blood CulturesThe low sensitivity of broad-range PCR (and even lower sensitivity of cultures and Gram stains) in the excised heart valves reported by Breitkopf et al1 may not be surprising if patients in this series, who were admitted mostly from other hospitals, had already received prolonged courses of antibiotics, after which they developed cardiac complications that resulted in operations to remove and replace infected valves. As expected, viable cultures and organisms visible on Gram stains of the valves may have disappeared even before the broad-range PCR (which does not require viable organisms, only remnant DNA) turned negative. PCR testing may revert to negative even before histopathologic (or gross) evidence of endocarditis clears. The importance of repeatedly positive blood cultures of common streptococci (and enterococci) or S aureus (echocardiographic findings notwithstanding) in this setting cannot be overemphasized. Positive blood cultures, although not absolutely required by Duke3 or modified Duke4 clinical criteria, were in fact present in 58% to 76% of definite cases reported in those series. Applying these blood culture criteria to the Breitkopf et al1 series should mean that 9 to 12 patients whose valves were infected with one of these organisms should have had positive blood cultures earlier; 7 did so (in addition, no blood culture data were available on 2 additional valves infected with these organisms). This suggests perhaps a low sensitivity of blood culture, which probably resulted from the use of antimicrobial therapy before blood cultures were taken. Of the remaining heart valves that were negative by molecular and conventional methods, 10 (43%) of 23 had positive blood cultures, a blood culture rate that is not different from the 8 (40%) of 20 whose valves were positive by PCR.Although the diagnosis of the causative pathogen in endocarditis is useful and important in guiding therapy, the diagnosis by heart valve analysis is unlikely to be helpful in guiding initial therapy in all but those who undergo emergency surgery for complications that require immediate excision of the infected valve(s). Even then, most of these are caused by S aureus, which usually can be diagnosed easily by blood culture. Although negative blood culture results may often be attributable to fastidious organisms, modern blood culture systems have gone a long way toward overcoming this limitation as long as an adequate number of blood cultures have been obtained before instituting antimicrobial therapy and the microbiology laboratory is advised about the possible diagnosis of endocarditis. PCR is most beneficial in the identification of organisms that cannot be cultivated from blood culture systems routinely. In circumstances under which organisms are easier to grow (eg, most of the streptococcal species) or where they often grow even in the presence of antibiotics (eg, staphylococcal species), the most common cause of culture negativity is that treatment was begun before adequate blood culturing was performed.Traditionally, it has been the opinion of many physicians caring for patients with endocarditis that at least 3 blood cultures should be taken during 1 hour in anyone suspected of having endocarditis before antimicrobial therapy is initiated. Defining who is suspected of having endocarditis and ensuring that all such patients are attended by physicians who share this point of view may be problematic and even impossible. Therefore, new and ingenious strategies to improve the sensitivity and specificity of PCR reactions to identify these patients are welcome. These strategies should include further reduction of background bacterial DNA (eg, at the time of DNA extraction); the use of long-range DNA polymerases to provide for more sequence information to minimize the number of PCR reactions (thereby diminishing the possibility of contamination); cleaner techniques for sample acquisition; and the application of these techniques to blood, the most relevant specimen in IE.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.FootnotesCorrespondence to Peter A. Rice, MD, Section of Infectious Diseases, Boston University Medical Center, 650 Albany St, Boston, MA 02118. E-mail [email protected] References 1 Breitkopf C, Hammel D, Scheld HH, Peters G, Becker K. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation. 2005; 111: 1415–1421.LinkGoogle Scholar2 Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med. 1981; 94: 505–518.CrossrefMedlineGoogle Scholar3 Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994; 96: 200–209.CrossrefMedlineGoogle Scholar4 Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000; 30: 633–638.CrossrefMedlineGoogle Scholar5 Corless CE, Guiver M, Borrow R, Edwards-Jones V, Kaczmarski EB, Fox AJ. Contamination and sensitivity issues with a real-time universal 16S rRNA PCR. J Clin Microbiol. 2000; 38: 1747–1752.CrossrefMedlineGoogle Scholar6 Rantakokko-Jalava K, Nikkari S, Jalava J, Eerola E, Skurnik M, Meurman O, Ruuskanen O, Alanen A, Kotilainen E, Toivanen P, Kotilainen P. Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol. 2000; 38: 32–39.CrossrefMedlineGoogle Scholar7 Wilson KH, Blitchington RB, Greene RC. Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J Clin Microbiol. 1990; 28: 1942–1946.CrossrefMedlineGoogle Scholar8 Greisen K, Loeffelholz M, Purohit A, Leong D. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol. 1994; 32: 335–351.CrossrefMedlineGoogle Scholar9 Kotilainen P, Jalava J, Meurman O, Lehtonen OP, Rintala E, Seppala OP, Eerola E, Nikkari S. Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluid. J Clin Microbiol. 1998; 36: 2205–2209.CrossrefMedlineGoogle Scholar10 Goldenberger D, Kunzli A, Vogt P, Zbinden R, Altwegg M. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol. 1997; 35: 2733–2739.CrossrefMedlineGoogle Scholar11 Rothman RE, Majmudar MD, Kelen GD, Madico G, Gaydos CA, Walker T, Quinn TC. Detection of bacteremia in emergency department patients at risk for infective endocarditis using universal 16S rRNA primers in a decontaminated polymerase chain reaction assay. J Infect Dis. 2002; 186: 1677–1681.CrossrefMedlineGoogle Scholar12 Fournier PE, Casalta JP, Habib G, Messana T, Raoult D. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med. 1996; 100: 629–633.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Boujelben I, Gdoura R and Hammami A (2018) A broad-range PCR technique for the diagnosis of infective endocarditis, Brazilian Journal of Microbiology, 10.1016/j.bjm.2017.03.019, 49:3, (534-543), Online publication date: 1-Jul-2018. Veinot J (2016) Pathologic Findings: Valvular Destruction, Perivalvular Abnormalities and Extracardiac Findings Endocarditis, 10.1007/978-3-319-27784-4_2, (9-30), . Maneg D, Sponsel J, Müller I, Lohr B, Penders J, Madlener K and Hunfeld K (2016) Advantages and Limitations of Direct PCR Amplification of Bacterial 16S-rDNA from Resected Heart Tissue or Swabs Followed by Direct Sequencing for Diagnosing Infective Endocarditis: A Retrospective Analysis in the Routine Clinical Setting, BioMed Research International, 10.1155/2016/7923874, 2016, (1-10), . Marsch G, Orszag P, Mashaqi B, Kuehn C and Haverich A (2015) Antibiotic therapy following polymerase chain reaction diagnosis of infective endocarditis: a single centre experience, Interactive CardioVascular and Thoracic Surgery, 10.1093/icvts/ivv006, 20:5, (589-593), Online publication date: 1-May-2015. Sabe M, Shrestha N and Menon V (2013) Contemporary Drug Treatment of Infective Endocarditis, American Journal of Cardiovascular Drugs, 10.1007/s40256-013-0015-6, 13:4, (251-258), Online publication date: 1-Aug-2013. Boussier R, Rogez S, François B, Denes E, Ploy M and Garnier F (2013) Two-step bacterial broad-range polymerase chain reaction analysis of heart valve tissue improves bacteriological diagnosis of infective endocarditis, Diagnostic Microbiology and Infectious Disease, 10.1016/j.diagmicrobio.2012.11.013, 75:3, (240-244), Online publication date: 1-Mar-2013. Veinot J (2012) Native Cardiac Valve Pathology, Surgical Pathology Clinics, 10.1016/j.path.2012.03.001, 5:2, (327-352), Online publication date: 1-Jun-2012. Kornreich B, Craven M, McDonough S, Nydam D, Scorza V, Assarasakorn S, Lappin M and Simpson K (2012) Fluorescence In-situ Hybridization for the Identification of Bacterial Species in Archival Heart Valve Sections of Canine Bacterial Endocarditis, Journal of Comparative Pathology, 10.1016/j.jcpa.2011.07.006, 146:4, (298-307), Online publication date: 1-May-2012. Sibley C, Peirano G and Church D (2012) Molecular methods for pathogen and microbial community detection and characterization: Current and potential application in diagnostic microbiology, Infection, Genetics and Evolution, 10.1016/j.meegid.2012.01.011, 12:3, (505-521), Online publication date: 1-Apr-2012. Gould F, Denning D, Elliott T, Foweraker J, Perry J, Prendergast B, Sandoe J, Spry M and Watkin R (2011) Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy, Journal of Antimicrobial Chemotherapy, 10.1093/jac/dkr450, 67:2, (269-289), Online publication date: 1-Feb-2012. Vondracek M, Sartipy U, Aufwerber E, Julander I, Lindblom D and Westling K (2011) 16S rDNA sequencing of valve tissue improves microbiological diagnosis in surgically treated patients with infective endocarditis, Journal of Infection, 10.1016/j.jinf.2011.04.010, 62:6, (472-478), Online publication date: 1-Jun-2011. de Sanctis J, Carpenter C, Sims M, SenGupta D, Prentice J, Cookson B and Boyanton B (2010) Culture-Negative Endocarditis and the Use of Molecular Diagnostics, Infectious Diseases in Clinical Practice, 10.1097/IPC.0b013e3181b7f7ee, 18:2, (120-123), Online publication date: 1-Mar-2010. Hunter D and Pepper J (2010) Infective Endocarditis Cardiovascular Critical Care, 10.1002/9781444314502.ch20, (347-366) Vollmer T, Piper C, Horstkotte D, Korfer R, Kleesiek K and Dreier J (2010) 23S rDNA real-time polymerase chain reaction of heart valves: a decisive tool in the diagnosis of infective endocarditis, European Heart Journal, 10.1093/eurheartj/ehp600, 31:9, (1105-1113), Online publication date: 1-May-2010. CHILD J, PEGUES D and PERLOFF J (2009) Infective Endocarditis and Congenital Heart Disease Congenital Heart Disease in Adults, 10.1016/B978-1-4160-5894-6.50012-5, (168-193), . Parahitiyawa N, Jin L, Leung W, Yam W and Samaranayake L (2009) Microbiology of Odontogenic Bacteremia: beyond Endocarditis, Clinical Microbiology Reviews, 10.1128/CMR.00028-08, 22:1, (46-64), Online publication date: 1-Jan-2009. Zakkar M, Chan K, Amirak E, Herrey A and Punjabi P (2009) Infective Endocarditis of the Mitral Valve: Optimal Management, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2008.08.007, 51:6, (472-477), Online publication date: 1-May-2009. Muñoz P, Bouza E, Marín M, Alcalá L, Rodríguez Créixems M, Valerio M and Pinto A (2008) Heart Valves Should Not Be Routinely Cultured, Journal of Clinical Microbiology, 10.1128/JCM.02173-07, 46:9, (2897-2901), Online publication date: 1-Sep-2008. Madico G and Rice P (2008) 16S-ribosomal DNA to diagnose culture-negative endocarditis, Current Infectious Disease Reports, 10.1007/s11908-008-0046-3, 10:4, (280-286), Online publication date: 1-Jul-2008. Döring G, Unertl K and Heininger A Validation criteria for nucleic acid amplification techniques for bacterial infections, Clinical Chemistry and Laboratory Medicine, 10.1515/CCLM.2008.152, 46:7 Syed F, Millar B and Prendergast B (2007) Molecular Technology in Context: A Current Review of Diagnosis and Management of Infective Endocarditis, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2007.08.002, 50:3, (181-197), Online publication date: 1-Nov-2007. Rahimtoola S (2006) The Year in Valvular Heart Disease, Journal of the American College of Cardiology, 10.1016/j.jacc.2005.11.023, 47:2, (427-439), Online publication date: 1-Jan-2006. Veinot J (2006) Pathologic Findings: Valvular Destruction, Perivalvular Abnormalities, and Extracardiac Findings Endocarditis, 10.1007/978-1-84628-453-3_2, (5-21), . March 22, 2005Vol 111, Issue 11 Advertisement Article InformationMetrics https://doi.org/10.1161/01.CIR.0000160383.67586.7BPMID: 15781748 Originally publishedMarch 22, 2005 Keywordspolymerase chain reactionEditorialsblood-borne pathogensvalvesendocarditisPDF download Advertisement SubjectsDiagnostic TestingInfectious Endocarditis
Referência(s)